Javier Torres Corredor

Real-world use of first-generation antiandrogens: impact on patient outcomes and subsequent therapies in metastatic castration-resistant prostate cancer

Richard Kelly, Angelyn Anton, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun Azad, Edmond Michael Kwan, Lavinia Spain, Arun Muthusamy, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Anthony Joshua, David Pook, Olivia Baenziger, Peter Gibbs, Ben Tran

Journal article  |  2021  |  BJU INTERNATIONAL

OBJECTIVES: To investigate the recent real-world use of first-generation antiandrogens (FGAs) in metastatic castration-resistant p..

Real-world incidence of symptomatic skeletal events and bone-modifying agent use in castration-resistant prostate cancer - an Australian multi-centre observational study.

Angelyn Anton, Shirley Wong, Julia Shapiro, Andrew Weickhardt, Arun Azad, Edmond M Kwan, Lavinia Spain, Ashray Gunjur, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Marie C Semira, Peter Gibbs, Ben Tran, Carmel Pezaro

Journal article  |  2021  |  Eur J Cancer

INTRODUCTION: Bone metastases occur frequently in castration-resistant prostate cancer (CRPC) and may lead to skeletal-related eve..

Uptake of bone modifying agents in patients with HER2 metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registry.

Vanessa Wong, Richard de Boer, Catherine Dunn, Angelyn Anton, Laeeq Malik, Sally Greenberg, Belinda Yeo, Louise Nott, Ian M Collins, Javier Torres, Frances Barnett, Michelle Nottage, Peter Gibbs, Sheau Wen Lok

Journal article  |  2021  |  Intern Med J

BACKGROUND AND AIM: International practice guidelines recommend administration of bone modifying agents (BMA) in metastatic breast..

Real-World Treatment and Outcomes of Metastatic Colorectal Cancer Patients With a Poor or Very Poor Performance Status

Avraham Travers, Azim Jalali, Stephen Begbie, Christine Semira, Suzanne Kosmider, Sumitra Ananda, Rachel Wong, Margaret Lee, Jeremy Shapiro, Matthew Burge, Desmond Yip, Javier Torres, Brigette Ma, Louise Nott, Andrew Dean, Jeanne Tie, Adnan Khattak, Stephanie Lim, Hui-li Wong, Peter Gibbs

Journal article  |  2021  |  CLINICAL COLORECTAL CANCER

BACKGROUND: The management of metastatic colorectal cancer patients with a poor performance status (PS) continues to be a clinical..

OA05.06 Lessons Learned from the Victorian Lung Cancer Registry: Opportunities for Quality Improvement in Lung Cancer Management and Outcomes

R Stirling, M Brand, A Earnest, P Antippa, D Ball, J Bartlett, R Blum, L Briggs, M Caldecott, M Conron, B Jennings, D Langton, J Millar, P Mitchell, I Olesen, P Parente, G Richardson, K See, J Torres, C Underhill, et al.

Conference Proceedings  |  2021  |  Journal of Thoracic Oncology

Potential reduction of hospital stay length with outpatient management of low-risk febrile neutropenia in a regional cancer center

Mike Nguyen, Tate Jacobson, Javier Torres, Alysson Wann

Journal article  |  2021  |  CANCER REPORTS

BACKGROUND: Febrile neutropenia is a serious complication of chemotherapy. The Multinational Association for Supportive Care in Ca..

Real-World Data on Outcomes in Metastatic Castrate-Resistant Prostate Cancer Patients Treated With Abiraterone or Enzalutamide: A Regional Experience.

Rachel Raju, Arvind Sahu, Myron Klevansky, Javier Torres

Journal article  |  2021  |  Front Oncol

Background: Both abiraterone and enzalutamide have shown to improve overall survival (OS), progression-free survival (PFS) and pro..

Real-world data on metastatic castration-resistant prostate cancer patients treated with abiraterone or enzalutamide: A regional experience

R Raju, A Sahu, M Klevansky, J Torres

Conference Proceedings  |  2020  |  ANNALS OF ONCOLOGY

Treatment outcomes for patients with metastatic castrate-resistant prostate cancer following docetaxel for hormone-sensitive disease

Andrew Schmidt, Angelyn Anton, Julia Shapiro, Shirley Wong, Arun Azad, Edmond Kwan, Lavinia Spain, Arun Muthusamy, Javier Torres, Phillip Parente, Francis Parnis, Jeffrey Goh, Anthony M Joshua, David Pook, Peter Gibbs, Ben Tran, Andrew Weickhardt

Journal article  |  2020  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

AIM: Optimal treatment for newly diagnosed metastatic hormone-sensitive prostate cancer (mHSPC) has evolved, with many patients de..

Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer

C Conduit, RH de Boer, S Lok, P Gibbs, L Malik, Z Loh, B Yeo, S Greenberg, B Devitt, J Lombard, M Nottage, I Collins, J Torres, M Nolan, L Nott

Journal article  |  2020  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

BACKGROUND: Anti-HER2 therapy-related cardiotoxicity is well described in the context of clinical trials, particularly in the sett..